Synexus has opened a research center in Bochum.
Synexus has opened a research center in Bochum, which is the company’s fourth in Germany and its 23rd in total. The clinic has moved from a much smaller site in Bochum and is situated in the historic Kortum House. The five hundred square meter clinic runs primary care clinical trials for major clinical research organizations and pharmaceutical companies and provides facilities for up to six professional investigators.
“Germany is one of our foremost locations for running clinical trials with its excellent medical expertise, a history of running clinical trials and a large population,” said Christophe Berthoux, CEO of Synexus. “Europe continues to be a favored region for our clients in the running of their global clinical trials and we are planning to further develop our business in Germany.”
The new clinic, which will be managed by Annette Kuehlenborg, is well placed for easy patient access because it is close to the main station and has parking facilities in the immediate vicinity. The company’s other German centers are in Frankfurt, Berlin, and Leipzig.
“This is a further step in our plan to update and expand our very successful network of clinics across Germany by providing modern clinics which benefit both our patients and our clients in pharma,” noted German Managing Director Christoph Dietrich. “Our success in bringing clinical trials to Germany is dependent on our ability to deliver patients and quality data. We have now put in place a sophisticated patient engagement program which improves the patient experience and it is these added-value extras which really pay dividends in terms of client success.”
All of Synexus’ 26 clinics across Europe and Africa focus particularly on undertaking cardiovascular, metabolic (diabetes and obesity), musculoskeletal, respiratory and central nervous system (dementia and pain) trials.
Read the full release here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.